Please ensure Javascript is enabled for purposes of website accessibility
Seagen Stock Quote


Price as of May 26, 2023, 3:00 p.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Seagen Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
SGEN +39.74% +246.82% +28.20% +2,245%
S&P +3.64% +54.54% +9.08% +233%

Seagen Company Info

Seagen is a biotechnology company that develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases.

News & Analysis

The Fool has written over 200 articles on Seagen.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.